MEGA SOCRA CCRP EXAM
COMPLETE CONTENT STUDY
GUIDE (Combining multiple sets
from other sources including
ACRP Actual Content) NEWEST
ACTUAL EXAM QUESTIONS
BANK / 750+ COMPLETE
ACCURATE QUIZZES WITH
DETAILED VERIFIED ANSWERS /
2025
Terms in this set (790)
With respect to IRB/IEC At least one member's primary area of interest is in a
membership, both the nonscientific area.
FDA
and ICH require that...
,Advertising for study subjects Be approved by the IRB/IEC prior to use.
must...
D. The protocol specifies how the clinical development
All of the following of an investigational product will be conducted.
statements regarding the
study protocol are true,
except:
A. The protocol describes the
objectives, design, and
methodologies of the trial. B.
The protocol should be
designed to protect the
rights, safety and welfare of
subjects.
C. The protocol
mustinclude sufficient
justification and rationale
for the conduct of the
research.
D. The protocol
specifieshow the clinical
development of an
investigational product will
be conducted.
,Which of the following A. The protocol describes the objectives, design, andmethodologies
statements regarding the of the trial.
study protocol are true? B. The protocol should be designed to protect therights, safety and
welfare of subjects.
A. The protocol describes the C. The protocol must include sufficient justification
objectives, design, and and rationale for the conduct of the research.
methodologies of the trial. B.
The protocol should be
designed to protect the
rights, safety and welfare of
subjects.
C. The protocol
mustinclude sufficient
justification and rationale
for the conduct of the
research.
D. The protocol
specifieshow the clinical
development of an
investigational product will
be conducted.
Obtain consent from the subject for the study
An unconscious adult subject
was enrolled in a study after
obtaining consent from an
LAR, and the protocol
therapy initiated. The subject
showed significant
improvement in his clinical
condition, and regained
consciousness. The
investigator should inform
the subject about the study
and:
, Documentation of IP Sponsor and PI
destruction at a site
should be maintained
by the:
Prior to agreeing to See enough patients who meet eligibility requirements
participate in a study, the
investigator should
consider whether they:
According to ICH GCP, an The subject or LAR is unable to read
impartial witness be present
during the informed consent
discussion when:
According to ICH GCP, who The subject's primary care physician
should be informed about
a subject's participation in
a trial?
B. New information arises which affects the safety of study
participants.
In which of the following
scenarios is re-consent
required?
A. The research
nurseleaves and a new one
is added to the study.
B. New information
ariseswhich affects the
safety of study participants.
C. The CT scanner
breaksand you to
reschedule the study visit.
D. It's been more than
30days since consent was
last obtained.
COMPLETE CONTENT STUDY
GUIDE (Combining multiple sets
from other sources including
ACRP Actual Content) NEWEST
ACTUAL EXAM QUESTIONS
BANK / 750+ COMPLETE
ACCURATE QUIZZES WITH
DETAILED VERIFIED ANSWERS /
2025
Terms in this set (790)
With respect to IRB/IEC At least one member's primary area of interest is in a
membership, both the nonscientific area.
FDA
and ICH require that...
,Advertising for study subjects Be approved by the IRB/IEC prior to use.
must...
D. The protocol specifies how the clinical development
All of the following of an investigational product will be conducted.
statements regarding the
study protocol are true,
except:
A. The protocol describes the
objectives, design, and
methodologies of the trial. B.
The protocol should be
designed to protect the
rights, safety and welfare of
subjects.
C. The protocol
mustinclude sufficient
justification and rationale
for the conduct of the
research.
D. The protocol
specifieshow the clinical
development of an
investigational product will
be conducted.
,Which of the following A. The protocol describes the objectives, design, andmethodologies
statements regarding the of the trial.
study protocol are true? B. The protocol should be designed to protect therights, safety and
welfare of subjects.
A. The protocol describes the C. The protocol must include sufficient justification
objectives, design, and and rationale for the conduct of the research.
methodologies of the trial. B.
The protocol should be
designed to protect the
rights, safety and welfare of
subjects.
C. The protocol
mustinclude sufficient
justification and rationale
for the conduct of the
research.
D. The protocol
specifieshow the clinical
development of an
investigational product will
be conducted.
Obtain consent from the subject for the study
An unconscious adult subject
was enrolled in a study after
obtaining consent from an
LAR, and the protocol
therapy initiated. The subject
showed significant
improvement in his clinical
condition, and regained
consciousness. The
investigator should inform
the subject about the study
and:
, Documentation of IP Sponsor and PI
destruction at a site
should be maintained
by the:
Prior to agreeing to See enough patients who meet eligibility requirements
participate in a study, the
investigator should
consider whether they:
According to ICH GCP, an The subject or LAR is unable to read
impartial witness be present
during the informed consent
discussion when:
According to ICH GCP, who The subject's primary care physician
should be informed about
a subject's participation in
a trial?
B. New information arises which affects the safety of study
participants.
In which of the following
scenarios is re-consent
required?
A. The research
nurseleaves and a new one
is added to the study.
B. New information
ariseswhich affects the
safety of study participants.
C. The CT scanner
breaksand you to
reschedule the study visit.
D. It's been more than
30days since consent was
last obtained.
